Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Acceptance and Efficacy of Live Supervision

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Central Institute of Mental Health, Mannheim
German Association for Behavior Therapy
Information provided by (Responsible Party):
Florian Weck, Goethe University
ClinicalTrials.gov Identifier:
NCT01510080
First received: December 12, 2011
Last updated: March 17, 2014
Last verified: March 2014
  Purpose

In order to meet an existing lack of empirical studies in the field of cognitive behavioral therapy supervision, the present randomized controlled trial is aimed at comparing two different types of supervision. This study compares computer-assisted live supervision and delayed video-based supervision regarding efficacy and acceptance among therapists, patients and supervisors. The efficacy of supervision is defined on different levels such as change of psychotherapeutic competence, nondisclosure, self-efficacy, self-awareness of the supervisee as well as therapeutic alliance, supervisory alliance and therapy outcome.


Condition Intervention
Mental Disorders
Behavioral: Computer-assisted live supervision
Behavioral: Delayed video-based supervision

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Live Supervision Put to Test - Studies of Acceptance and Efficacy of Computer-assisted Live Supervision

Resource links provided by NLM:


Further study details as provided by Goethe University:

Primary Outcome Measures:
  • Supervisory Questionnaire (SQ) [ Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks ] [ Designated as safety issue: No ]
    self-report measure that assesses nondisclosure of the supervisee during supervision

  • Supervisee Levels Questionnaire (SLQ-R) [ Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks ] [ Designated as safety issue: No ]
    self-report measure that assesses self awareness, motivation and dependency- autonomy of supervisees

  • Counseling Self-Estimate Inventory (COSE) [ Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks ] [ Designated as safety issue: No ]
    self-report measure that assesses self efficacy of the supervisee

  • Fragebogen zur Psychotherapie-Supervision Kurzform (FSPT-K) [ Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks ] [ Designated as safety issue: No ]
    self-report measure that assesses level of development and supervision needs of the therapist


Secondary Outcome Measures:
  • Helping Alliance Questionnaire (HAQ) [ Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks ] [ Designated as safety issue: No ]
    self-report measure that assesses the therapeutic alliance

  • Supervisory Working Alliance Inventory (SWAI) [ Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks ] [ Designated as safety issue: No ]
    self-report measure that assesses the supervisory relationship

  • Beck-Depression Inventory II (BDI-II) [ Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks ] [ Designated as safety issue: No ]
    self-report measure that assesses depressive symptoms

  • Beck Anxiety Inventory II (BAI) [ Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks ] [ Designated as safety issue: No ]
    self-report measure that asessses anxiety symptoms

  • Brief Symptom Inventory (BSI) [ Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks ] [ Designated as safety issue: No ]
    self-report measure that assesses aspects of general psychopathology

  • Health-related quality of life (SF-12) [ Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks ] [ Designated as safety issue: No ]
    self-report measure that assesses the health-related quality of life

  • Client Satisfaction Questionnaire (CSQ8) [ Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks ] [ Designated as safety issue: No ]
    self-report measure that assesses satisfaction with therapy

  • Stundenbogen zur Supervisionsbeurteilung (STEP SV) [ Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks ] [ Designated as safety issue: No ]
    self-report measure that assesses satisfaction with supervision

  • Cognitive Therapy Scale (CTS) [ Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks ] [ Designated as safety issue: No ]
    clinician-rated measure that assesses psychotherapeutic competencies


Estimated Enrollment: 40
Study Start Date: January 2012
Estimated Study Completion Date: July 2014
Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Computer-assisted live supervision
Supervisees assigned to this group will receive 8 sessions of computer-assisted live supervision and 4 sessions of delayed video-based supervision while treating 2 patients during 26 therapy sessions each. Computer-assisted live supervision is also known as "bug-in-the-eye" (BITE) supervision. The supervisor observes the therapy session with the help of a webcam and types messages on his computer. The instructions to the supervisee appear on a second monitor located in the therapy room where the supervisee can view it whenever he wants to.
Behavioral: Computer-assisted live supervision
8 BITE sessions, 4 video-based sessions (each 50 minutes) during treatment of 2 patients
Other Names:
  • "bug-in-the-eye" (BITE) supervision
  • video-based live supervision
  • monitor-based live supervision
Experimental: Delayed video-based supervision
Supervisees assigned to this group will receive 12 sessions of delayed video-based supervision while treating 2 patients during 26 therapy sessions each. During delayed video-based supervision the supervisor and the supervisee spend 50 minutes reviewing selected parts of video recorded therapy sessions and discussing the case.
Behavioral: Delayed video-based supervision
12 video-based sessions (each 50 minutes) during treatment of 2 patients
Other Name: videotape supervision

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Supervisees

Inclusion Criteria:

  • Having successfully completed the interim audit
  • Having started to treat ambulant patients under supervision

Exclusion Criteria:

-

Patients

Inclusion Criteria:

  • Meeting ICD 10 criteria for a mental disorder
  • Informed consent

Exclusion Criteria:

  • Currently in psychotherapy
  • Suicidal tendency
  • Clinical diagnosis of alcohol or drug addiction, acute schizophrenia, schizoaffective disorder or bipolar disorder
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01510080

Locations
Germany
Department of Clinical Psychology and Psychotherapy of the Wolfgang Goethe University
Frankfurt, Hessen, Germany, D-60486
Sponsors and Collaborators
Goethe University
Central Institute of Mental Health, Mannheim
German Association for Behavior Therapy
Investigators
Principal Investigator: Florian Weck, PhD Goethe University
Study Director: Martin Bohus, MD Central Institute of Mental Health
  More Information

No publications provided

Responsible Party: Florian Weck, Principal Investigator, Goethe University
ClinicalTrials.gov Identifier: NCT01510080     History of Changes
Other Study ID Numbers: WECK-012
Study First Received: December 12, 2011
Last Updated: March 17, 2014
Health Authority: Germany: Ethics Commission

Keywords provided by Goethe University:
Computer-assisted live supervision
"Bug-in-the-eye" supervision
Delayed video-based supervision
Cognitive behavioral therapy supervision

Additional relevant MeSH terms:
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on November 25, 2014